Stereotaxis Inc

$2.09
(as of May 30, 9:30 AM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Stereotaxis Inc

Stock Price
$2.09
Ticker Symbol
STXS
Exchange
NYSE MKT

Industry Information for Stereotaxis Inc

Sector
Healthcare
Industry
Medical Instruments & Supplies

Company Description for Stereotaxis Inc

Country
USA
Full Time Employees
139

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is designed to enhance the accessibility of RMN by eliminating the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; V-CAS; and MAGiC catheter for cardiac ablation procedures. Further, it provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Fundamentals for Stereotaxis Inc

Market Capitalization
$173,678,992
EBITDA
$-21,521,000
Dividends per Share
P/E Ratio
Forward P/E Ratio
0
Earnings per Share
$-0.30
Earnings per Share Estimate Next Year
Profit Margin
-89.33%
Shares Outstanding
85,979,696
Percent Owned by Insiders
31.61%
Percent Owned by Institutions
48.93%
52-Week High
52-Week Low

Technical Indicators for Stereotaxis Inc

50-Day Moving Average
200-Day Moving Average
RSI
58.99
0.1

Analyst Ratings for Stereotaxis Inc

Strong Buy
2
Buy
2
Hold
0
Sell
0
Strong Sell
0

News About Stereotaxis Inc

May 12, 2025, 4:01 PM EST
Apr 23, 2025, 7:10 AM EST
Thermo Fisher Scientific (TMO) came out with quarterly earnings of $5.15 per share, beating the Zacks Consensus Estimate of $5.10 per share. See more.
Apr 22, 2025, 7:00 AM EST
Apr 21, 2025, 8:00 AM EST